Advertisement
Advertisement
PEN
Penumbra, Inc.
322.59
USDSponsored
-0.20
-0.06%
May 13, 16:00 UTC -4
Closed
After-Market
322.73
+0.14
+0.04%
PEN Earnings Reports
Positive Surprise Ratio
PEN beat 35 of 42 last estimates.
83%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$392.68M
/$1.20
Implied change from Q1 26 (Revenue/ EPS)
+4.78%
/+46.34%
Implied change from Q2 25 (Revenue/ EPS)
+15.68%
/+39.53%
Penumbra, Inc. earnings per share and revenue
On May 06, 2026, PEN reported earnings of 0.82 USD per share (EPS) for Q1 26, missing the estimate of 1.08 USD, resulting in a -24.49% surprise. Revenue reached 374.76 million, compared to an expected 374.82 million, with a -0.02% difference. The market reacted with a -0.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analysts forecast an EPS of 1.20 USD, with revenue projected to reach 392.68 million USD, implying an increase of 46.34% EPS, and increase of 4.78% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Anteris Technologies Global Corp. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.28
Surprise
-78.80%
Neuropace, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.13
Surprise
+44.59%
ClearPoint Neuro, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.32
Surprise
-20.66%
Hyperfine, Inc. Class A Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.31
Surprise
-23.21%
QT Imaging Holdings, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.25
Surprise
-81.29%
Xtant Medical Holdings, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.01
Actual
-$0.02
Surprise
-17.65%
Spectral AI, Inc. Class A Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.11
Surprise
-19.83%
Adagio Medical Holdings, Inc Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.31
Surprise
-4.27%
Precision Optics Corporation, Inc. Common Stock
Report Date
May 13, 2026 For Q3 26
Estimate
-Actual
-$0.01
Surprise
-
FAQ
What were Penumbra, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Penumbra, Inc. reported EPS of $0.82, missing estimates by -24.49%, and revenue of $374.76M, -0.02% below expectations.
How did the market react to Penumbra, Inc.'s Q1 2026 earnings?
The stock price moved down -0.58%, changed from $329.89 before the earnings release to $327.98 the day after.
When is Penumbra, Inc. expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for Penumbra, Inc.'s next earnings report?
Based on 17
analysts, Penumbra, Inc. is expected to report EPS of $1.20 and revenue of $392.68M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement